Quick answers
- What is Cequa?
- Cequa is a brand name of Cyclosporine, a prescription medicine. The FDA NDC Directory lists 2 Cequa products in 2 strengths and forms.
- Who makes Cequa?
- Sun Pharm holds the FDA application for Cequa (NDA210913, approved August 14, 2018).
- Is there a generic or store brand of Cequa?
- Other products of Cyclosporine are listed with the FDA, but none in exactly the same strength and form as a Cequa product.
- What do pharmacies pay for Cequa?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Cequa strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Cequa been recalled?
- FDA enforcement reports list 4 recalls of Cequa products; the newest started September 7, 2023. A recall usually concerns specific lots, not every product.
What Cequa is
Each Cequa product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Cyclosporine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| cyclosporine 0.0009 g/mL solution/ drops (ophthalmic, topical) | Cequa | None listed | DailyMed |
| cyclosporine 0.0009 mg/mL solution/ drops (ophthalmic, topical) | Cequa | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cyclosporine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA210913 | Sun Pharm | August 14, 2018 | 2 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| cyclosporine 0.0009 g/mL solution/ drops | Brand: Cequa | $10.39 per unit |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Cequa
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cequa products.
- Sun Pharmaceutical Industries, Inc.2 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
September 7, 2023 · Class III · Terminated · D-1172-2023
Subpotent: Out of Specification result observed for low assay
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-5 — SUN PHARMACEUTICAL INDUSTRIES INC
-
April 1, 2022 · Class III · Terminated · D-0770-2022
Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.
Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) per box, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, ZI de la Guerie, F-50211 Coutances Cedex — SUN PHARMACEUTICAL INDUSTRIES INC
-
May 7, 2021 · Class III · Terminated · D-0391-2021
Subpotent and Presence of Particulates .
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed — SUN PHARMACEUTICAL INDUSTRIES INC
-
February 22, 2021 · Class III · Terminated · D-0289-2021
Subpotent
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-5 — SUN PHARMACEUTICAL INDUSTRIES INC
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.